Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 75301-75350 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05688579
Effect of MRA on Cardiovascular Disease in Patients With Hypertension and Hyperaldosteronemia
PHASE4Enrolling by invitation
8,000 participants
Started: Apr 16, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05872659
Mesenchymal Stem Cells for Immune Non-responder Patients With HIV Infection
EARLY_PHASE1Recruiting
20 participants
Started: Apr 16, 2023 · Completed: Nov 15, 2025
2 conditions2 sponsors1 location
NCT05802602
Porcine Membrane vs Bovine Wound Dressing in Human Tooth Extraction Sites
NARecruiting
24 participants
Started: Apr 16, 2023 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT05757934
Exploring the Long-term Cardiovascular Effects of Vaping
N/AActive, not recruiting
172 participants
Started: Apr 16, 2023 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT05375812
NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH IN-DEPTH)
N/ARecruiting
85 participants
Started: Apr 16, 2023 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT06068582
Don't be Late! Postponing Cognitive Decline and Preventing Early Unemployment in People With Multiple Sclerosis
NARecruiting
270 participants
Started: Apr 16, 2023 · Completed: Sep 30, 2026
1 condition7 sponsors1 location
NCT06324266
Study on the Efficacy and Safety of Low-dose CTX as Maintenance Therapy for MM Unsuitable for Transplantation
PHASE2/PHASE3Recruiting
80 participants
Started: Apr 16, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06579560
Audio Vestibular Assessment in Patients with Fibromyalgia
N/ARecruiting
4 participants
Started: Apr 16, 2023 · Completed: Apr 16, 2025
1 condition1 sponsor1 location
NCT05792462
Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum Disorders
PHASE1/PHASE2Recruiting
12 participants
Started: Apr 15, 2023 · Completed: Dec 30, 2025
1 condition3 sponsors1 location
NCT05811793
Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.
NANot yet recruiting
36 participants
Started: Apr 15, 2023 · Completed: Dec 30, 2025
1 condition2 sponsors0 locations
NCT05791591
Safety and Efficacy of Orally Administered NUV001 Nutraceutical Supplement in Sickle Cell Disease Patients
NAActive, not recruiting
168 participants
Started: Apr 15, 2023 · Completed: Nov 30, 2024
1 condition2 sponsors8 locations
NCT05229055
Intranasal Ketamine Versus Subcutaneous Ketamine for Treatment of Post-traumatic Acute Pain in the Emergency Department ( INVESCK )
PHASE2/PHASE3Recruiting
1,000 participants
Started: Apr 15, 2023 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT05064241
Overcoming Barriers to Accessing Genetic Medicine
NAActive, not recruiting
70 participants
Started: Apr 15, 2023 · Completed: Sep 30, 2025
2 conditions2 sponsors1 location
NCT05890209
Optimizing Weight Loss. Can Continuous Glucose Monitoring Play a Role
NAActive, not recruiting
49 participants
Started: Apr 15, 2023 · Completed: Oct 15, 2024
2 conditions1 sponsor1 location
NCT06368011
The Impact of Acceptance and Commitment Therapy on Stigmatization
NAEnrolling by invitation
36 participants
Started: Apr 15, 2023 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT05814731
Study on the Efficacy and Safety of MA-BUCY2 Conditioning in High-risk AML Patients Underwent Haplo-HSCT
NANot yet recruiting
264 participants
Started: Apr 15, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05814718
Modified BEAM Regimen for T Cell Lymphoma Underwent ASCT
NANot yet recruiting
122 participants
Started: Apr 15, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05603910
Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma
PHASE1Recruiting
18 participants
Started: Apr 15, 2023 · Completed: Apr 15, 2030
2 conditions1 sponsor1 location
NCT05805176
An Adjunct Study to Assess Guided ADHD Therapy for Managing the Extent and Severity of Symptoms
NAActive, not recruiting
194 participants
Started: Apr 15, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor5 locations
NCT05797363
The Effect of Continuous Midwife Support on Various Parameters Related to Pregnancy, Childbirth and Postpartum Period
NANot yet recruiting
150 participants
Started: Apr 15, 2023 · Completed: Dec 30, 2027
3 conditions1 sponsor0 locations
NCT05746546
Depressed Mood Improvement Through Nicotine Dosing-3 (Depressed MIND3) Extension
PHASE2Recruiting
60 participants
Started: Apr 15, 2023 · Completed: Oct 31, 2026
1 condition2 sponsors1 location
NCT06391970
Digital Cognition Study During Long-COVID
NARecruiting
300 participants
Started: Apr 15, 2023 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT05930886
Focus Groups in Ethnically and Racially Diverse Families
N/ARecruiting
30 participants
Started: Apr 15, 2023 · Completed: Oct 4, 2025
3 conditions1 sponsor1 location
NCT05661448
Promoting Cognitive Health in Schizophrenia
NARecruiting
390 participants
Started: Apr 15, 2023 · Completed: Aug 31, 2029
2 conditions3 sponsors5 locations
NCT05803863
Efficacy Comparison of 2 Low-dose Atropine Eye Drops in Vietnamese Children Myopia Management
PHASE4Not yet recruiting
108 participants
Started: Apr 15, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05859867
Bimbingamba Zerosix Third Phase: Studying Communities
NARecruiting
2,000 participants
Started: Apr 15, 2023 · Completed: Dec 31, 2025
4 conditions2 sponsors1 location
NCT04536480
Time Limited Eating in Adolescents With Type 2 Diabetes (KT2D)
NARecruiting
100 participants
Started: Apr 15, 2023 · Completed: Dec 1, 2027
3 conditions1 sponsor1 location
NCT06202703
Fine Needle aSpiration of Lymph nodEs to Study vAccine-induced Immunity
NARecruiting
5 participants
Started: Apr 15, 2023 · Completed: Oct 15, 2024
1 condition1 sponsor1 location
NCT06342401
Early Onset Colorectal Cancer Detection
N/ARecruiting
400 participants
Started: Apr 15, 2023 · Completed: Oct 15, 2025
8 conditions1 sponsor13 locations
NCT04287192
Digital Bridge: Using Technology to Support Patient-centered Care Transitions From Hospital to Home
NARecruiting
640 participants
Started: Apr 15, 2023 · Completed: Mar 30, 2026
1 condition3 sponsors1 location
NCT05735340
Type 1 Diabetes Education and Support Study
NAActive, not recruiting
40 participants
Started: Apr 15, 2023 · Completed: Feb 15, 2026
1 condition3 sponsors1 location
NCT06200090
Empathy and Emotional Regulation: A Multi-National Cross-Sectional Study
N/ARecruiting
1,987 participants
Started: Apr 15, 2023 · Completed: Feb 1, 2024
3 conditions1 sponsor1 location
NCT05927818
Sentinel Lymph Node Biopsy in Early-Stage Ovarian Cancer
NARecruiting
100 participants
Started: Apr 15, 2023 · Completed: Jan 15, 2026
2 conditions1 sponsor1 location
NCT05760573
The Ready and Healthy for Kindergarten Study
NAActive, not recruiting
396 participants
Started: Apr 15, 2023 · Completed: Nov 30, 2026
4 conditions2 sponsors1 location
NCT06083025
Influence of CleaRing Open-capsule Device on Refractive Predictability in Cataract Patients (Part 2)
NARecruiting
25 participants
Started: Apr 15, 2023 · Completed: Apr 1, 2025
1 condition1 sponsor1 location
NCT05444504
Effectiveness and Acceptability of Insertable Devices for Obstetric Fistula Management
NARecruiting
100 participants
Started: Apr 15, 2023 · Completed: Dec 1, 2026
4 conditions5 sponsors3 locations
NCT06425354
Use of 'Mechanical Power' as a Predictor of Increased Serum and Pulmonary Proinflammatory Cytokine Concentrations in Patients With Acute Hypoxemic Respiratory Failure: A Prospective Observational Study
N/ARecruiting
150 participants
Started: Apr 15, 2023 · Completed: Jun 15, 2027
1 condition1 sponsor1 location
NCT06153225
Amino Acid Concentrations in Serum After Intake of Different Protein Sources
NARecruiting
32 participants
Started: Apr 15, 2023 · Completed: Mar 31, 2024
1 condition1 sponsor1 location
NCT05746273
Depressed Mood Improvement Through Nicotine Dosing 3
PHASE2Recruiting
60 participants
Started: Apr 15, 2023 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT05716984
rhBNP in Type 3 Pulmonary Hypertension
PHASE4Enrolling by invitation
72 participants
Started: Apr 15, 2023 · Completed: Mar 30, 2024
1 condition1 sponsor2 locations
NCT05205317
Comparison of the Therapeutic Effects of VR and VR + Metformin in the Treatment of Cesarean Section Scar Defect
NARecruiting
100 participants
Started: Apr 15, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05742230
Effect of Henagliflozin on Cardiac Function in Type 2 Diabetes Patients With Chronic Heart Failure (HERO-HF)
NARecruiting
1,932 participants
Started: Apr 15, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05832723
A Real-world Study of 650nm Low-intensity Single-wavelength Red Light for Children and Adolescents
N/ARecruiting
2,000 participants
Started: Apr 15, 2023 · Completed: Mar 28, 2026
1 condition1 sponsor1 location
NCT05571735
Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients
N/AActive, not recruiting
133 participants
Started: Apr 15, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06081062
Evaluate the Safety and Efficacy of Fabagal® (Agalsidase Beta) in Patients With Fabry Disease
PHASE3Recruiting
24 participants
Started: Apr 14, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT05779163
A Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors
PHASE1/PHASE2Recruiting
468 participants
Started: Apr 14, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor6 locations
NCT05824988
Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung Disease
N/ARecruiting
100 participants
Started: Apr 14, 2023 · Completed: Oct 31, 2026
4 conditions5 sponsors1 location
NCT05899725
The Efficacy and Safety of Corticosteroids in Combination With Ruxolitinib in the Management of Checkpoint Inhibitor Pneumonia
NARecruiting
60 participants
Started: Apr 14, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05773040
A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas
PHASE1Recruiting
33 participants
Started: Apr 14, 2023 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT05734547
Stepping Together for Children After Trauma, Norway
NARecruiting
160 participants
Started: Apr 14, 2023 · Completed: Dec 1, 2028
4 conditions4 sponsors2 locations